FRANCOLINI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 6.356
EU - Europa 3.668
AS - Asia 3.488
SA - Sud America 342
Continente sconosciuto - Info sul continente non disponibili 104
AF - Africa 71
OC - Oceania 41
AN - Antartide 1
Totale 14.071
Nazione #
US - Stati Uniti d'America 6.219
RU - Federazione Russa 1.399
SG - Singapore 1.018
CN - Cina 975
IT - Italia 869
HK - Hong Kong 501
KR - Corea 297
PL - Polonia 290
BR - Brasile 272
VN - Vietnam 259
IE - Irlanda 244
SE - Svezia 183
DE - Germania 182
FR - Francia 182
FI - Finlandia 102
IN - India 94
GB - Regno Unito 89
CA - Canada 87
JO - Giordania 81
BD - Bangladesh 76
ID - Indonesia 41
AU - Australia 39
AR - Argentina 31
JP - Giappone 30
NL - Olanda 28
IQ - Iraq 25
MX - Messico 22
ES - Italia 19
TR - Turchia 16
ZA - Sudafrica 15
BE - Belgio 13
CH - Svizzera 12
CI - Costa d'Avorio 11
CZ - Repubblica Ceca 10
EC - Ecuador 10
NG - Nigeria 10
UA - Ucraina 10
VE - Venezuela 10
LT - Lituania 9
PK - Pakistan 8
SA - Arabia Saudita 8
TN - Tunisia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
MA - Marocco 7
CL - Cile 6
KE - Kenya 6
KZ - Kazakistan 6
PH - Filippine 6
IL - Israele 5
TT - Trinidad e Tobago 5
CO - Colombia 4
CR - Costa Rica 4
UY - Uruguay 4
AT - Austria 3
BJ - Benin 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
KG - Kirghizistan 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
CG - Congo 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
GE - Georgia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
Totale 13.962
Città #
Santa Clara 1.271
Ashburn 875
Singapore 755
Hong Kong 442
Fairfield 390
Seoul 296
Chandler 291
San Jose 287
Warsaw 280
Hefei 277
Dublin 242
Woodbridge 205
Seattle 195
Houston 158
Cambridge 149
Beijing 144
Wilmington 142
Milan 135
Los Angeles 125
Munich 111
Council Bluffs 101
Buffalo 95
Ann Arbor 87
Ho Chi Minh City 83
Rome 81
Dearborn 77
Florence 77
Paris 75
New York 70
Lauterbourg 67
Lawrence 66
Moscow 66
Altamura 65
The Dalles 63
Princeton 53
Hanoi 51
Kent 51
Shanghai 50
Helsinki 48
Boston 38
São Paulo 37
Melbourne 34
San Diego 32
Mumbai 30
Turku 30
Frankfurt am Main 29
Chicago 27
London 27
Clifton 26
Medford 26
Jakarta 24
Naples 24
Brooklyn 22
Dallas 22
Tokyo 21
Montreal 20
Orem 20
Toronto 19
San Francisco 17
Bengaluru 16
Phoenix 16
Stockholm 16
Boardman 14
Bologna 14
Chennai 14
Guangzhou 14
Turin 14
Baghdad 13
Brussels 13
Genoa 13
Lappeenranta 13
Shenzhen 12
Abidjan 11
West Jordan 11
Atlanta 10
Bari 10
Brescia 10
Da Nang 10
Dong Ket 10
Figino 10
Haiphong 10
Pune 10
Abuja 9
Belo Horizonte 9
Denver 9
Johannesburg 9
Salt Lake City 9
Amsterdam 8
Cascina 8
Falls Church 8
Miano 8
Padua 8
Poplar 8
Tashkent 8
Venice 8
Yubileyny 8
Elk Grove Village 7
Manchester 7
Mexico City 7
Nanjing 7
Totale 9.050
Nome #
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 402
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 297
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 282
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 267
Pros-IT CNR: an Italian prostate cancer monitoring project 249
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 249
Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma 245
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 240
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 237
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 228
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 224
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 222
Influence of age and subtype in outcome of operable liposarcoma 220
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 219
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 218
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 216
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 212
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 211
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 208
Methodological approach to create an atlas using a commercial auto-contouring software 206
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 205
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 199
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 197
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 195
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 194
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions 192
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 191
Thermal Ablation versus SBRT in liver tumours: pros and cons 191
Prognostic Impact of Post-Diagnosis Smoking Cessation among Bladder Cancer Patients: A Systematic Literature Review and Meta-Analysis 190
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 189
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 188
Enhancing patient safety in radiotherapy: Implementation of a customized electronic checklist for radiation therapists 186
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series 186
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 184
Artificial Intelligence in radiotherapy: state of the art and future directions 184
Impact of COVID-19 on workload burden of a complex radiotherapy facility 184
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 183
Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy 181
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 180
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 178
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 173
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 172
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 172
Clinical validation of an automatic atlas-based segmentation tool for male pelvis CT images 172
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity 170
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 168
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 167
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 166
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 166
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 163
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 162
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis 160
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 158
Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art 156
In reply to Egger et al.: Lack of benefit from adjuvant postoperative radiotherapy and issues raised about upfront management of high- and very-high-risk prostate cancer patients 155
In reply to: Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer 152
Prognostic impact of nodal relapse in definitive prostate-only irradiation 151
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 146
Preoperative radiotherapy: A paradigm shift in the treatment of breast cancer? A review of literature 146
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients 145
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trial 145
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literature 145
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 144
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 144
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) 143
Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques 142
May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk? 141
Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience 140
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 136
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors 134
The use of psychological supportive care services and psychotropic drugs in patients with early-stage breast cancer: a comparison between two institutions on two continents 131
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer 119
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 114
Radiomic Analysis for Human Papillomavirus Assessment in Oropharyngeal Carcinoma: Lessons and Pitfalls for the Next Future 97
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial 95
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914) 70
null 57
Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomes 44
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial 29
Italian adaptation of the European guidelines for breast cancer diagnosis, staging, and preoperative planning: a GRADE-ADOLOPMENT approach 27
The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease 25
Totale 14.071
Categoria #
all - tutte 42.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022376 0 10 38 32 16 20 12 37 17 19 65 110
2022/20231.200 77 229 65 49 99 212 143 84 177 6 32 27
2023/2024681 23 52 71 32 37 99 38 178 9 35 73 34
2024/20254.179 121 350 215 636 1.140 512 68 279 231 147 185 295
2025/20265.256 583 659 525 406 593 172 651 245 326 349 225 522
2026/2027445 173 272 0 0 0 0 0 0 0 0 0 0
Totale 14.071